Table 1.
Characteristics of the Carolina Endometrial Cancer Study participants who participated in the home visit pilot study with vaginal swab and stool sample self-collection.
Fig 1.
Distribution of self-reported comfort levels with the collection process for stool (N = 43) and vaginal swab (N = 47) samples.
Fig 2.
Stool sample and vaginal swab microbiome diversity profiles according to histology type (endometrioid vs. non-endometrioid): a. alpha diversity (Shannon index) for stool sample microbiome; b. beta diversity (Bray-Curtis) for stool sample microbiome; c. alpha diversity (Shannon index) for vaginal swab microbiome; d. beta diversity (Bray-Curtis) for vaginal swab microbiome.
Fig 3.
Stool sample and vaginal swab microbiome diversity profiles according to cancer treatment (any chemotherapy/radiation vs. surgery only): a. alpha diversity (Shannon index) for stool sample microbiome; b. beta diversity (Bray-Curtis) for stool sample microbiome; c. alpha diversity (Shannon index) for vaginal swab microbiome; d. beta diversity (Bray-Curtis) for vaginal swab microbiome.
Table 2.
Characteristics of the vaginal microbiome study samples by vagitype (N = 40).
Fig 4.
Relative abundance of vaginal microbiome genera by vagitype (Lactobacillus dominant vs. non-Lactobacillus dominant vagitypes).
Fig 5.
Volcano plot of differentially abundant bacterial genera in vaginal microbiome according to cancer treatment (any chemotherapy/radiation vs. surgery only).